Radius Health Shares Up 15% Premarket, Likely on the Heels of Concerning Adverse Side Effect Data from Amgen on Its Osteoporosis Treatment; BZ NOTE: Radius' Competing Product to Amgen's Evenity is Called Tymlos
Paul Quintaro